CRISPR/Cas9‐mediated editing will lead to HDR‐dependent insertion of a stop codon that terminates EGFR translation at exon 19 or 20, or an NHEJ‐dependent random insertion/deletion, destroying EGFR TK activity and cancer progression. Here, TKT is linked to cancer.